A Novel Anti‑EGFR Monoclonal Antibody (EMab‑17) Exerts Antitumor Activity Against Oral Squamous Cell Carcinomas via Antibody‑dependent Cellular Cytotoxicity and Complement‑dependent Cytotoxicity
Oncology Letters - Greece
doi 10.3892/ol.2020.11384
Full Text
Open PDFAbstract
Available in full text
Date
February 10, 2020
Authors
Publisher
Spandidos Publications